2025
SJR Q1
JCR Q1 · 6,3
65 matched articles
SCIE
Journal detail
Inflammopharmacology
- Publisher
- Springer Science and Business Media Deutschland GmbH
- Country
- Switzerland · Western Europe
- Type
- journal
- ISSN
-
0925469215685608
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 1,373
- Quartile Q1
- H-Index 81
- Cites/doc 6,79
- Docs (3y) 658
- Cites (3y) 4.379
Clarivate
Web of Science · JCR · 2025
- JCR Q Q1
- JIF 6,3
- 5Y JIF 6
- JCI 1,14
WoS indexes
- SCIE
Subject classification
Categories (SJR)
- Immunology Q1
- Pharmacology Q1
- Pharmacology (medical) Q1
Areas
- Immunology and Microbiology
- Medicine
- Pharmacology, Toxicology and Pharmaceutics
WoS categories
- Immunology | Toxicology
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q1 | Q1 | 1,373 | 6,3 | 6 | 1,14 | Q1 | 81 |
| 2024 | Q1 | Q1 | 1,269 | 5,3 | 5,2 | 1,09 | Q1 | 74 |
| 2023 | Q1 | Q1 | 0,952 | 4,6 | 4,5 | 1,07 | Q1 | 74 |
| 2022 | Q1 | Q1 | 0,932 | 5,8 | 5,4 | 1,04 | Q1 | 74 |
| 2021 | Q2 | Q1 | 0,772 | 5,1 | 5 | 0,98 | Q1 | 74 |
| 2020 | Q2 | Q1 | 0,945 | 4,5 | 4,7 | 1,02 | Q1 | 74 |
| 2019 | Q2 | Q2 | 0,729 | 3,2 | 3,4 | 0,92 | Q2 | 74 |
| 2018 | — | Q1 | — | 3,8 | 3,5 | 0,94 | Q2 | — |
| 2017 | Q2 | Q1 | 0,925 | 3,3 | — | 0,77 | Q2 | 74 |
| 2016 | Q2 | Q2 | 0,941 | 2,6 | — | — | — | 74 |
| 2015 | Q2 | Q2 | 1,031 | 2,3 | — | — | — | 74 |
| 2014 | Q1 | — | 1,056 | — | — | — | — | 74 |
| 2013 | Q2 | — | 0,795 | — | — | — | — | 74 |
| 2012 | Q2 | — | 0,529 | — | — | — | — | 74 |
| 2011 | Q2 | — | 0,849 | — | — | — | — | 74 |
| 2010 | Q2 | — | 0,723 | — | — | — | — | 74 |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | IMMUNOLOGY | SCIE | Q1 | Q1 | 34/183 |
| 2025 | TOXICOLOGY | SCIE | Q1 | Q1 | 11/106 |
| 2024 | IMMUNOLOGY | SCIE | Q1 | Q1 | 40/183 |
| 2024 | TOXICOLOGY | SCIE | Q1 | Q1 | 13/106 |
| 2023 | IMMUNOLOGY | SCIE | Q2 | Q1 | 56/181 |
| 2023 | TOXICOLOGY | SCIE | Q1 | Q1 | 17/106 |
| 2022 | IMMUNOLOGY | SCIE | Q2 | Q1 | 51/161 |
| 2022 | TOXICOLOGY | SCIE | Q1 | Q1 | 11/94 |
| 2021 | IMMUNOLOGY | SCIE | Q2 | Q2 | 74/162 |
| 2021 | TOXICOLOGY | SCIE | Q1 | Q1 | 19/94 |
| 2020 | IMMUNOLOGY | SCIE | Q2 | Q2 | 72/162 |
| 2020 | TOXICOLOGY | SCIE | Q1 | Q1 | 23/93 |
| 2019 | IMMUNOLOGY | SCIE | Q3 | Q2 | 85/159 |
| 2019 | TOXICOLOGY | SCIE | Q2 | Q2 | 33/92 |
| 2018 | IMMUNOLOGY | SCIE | Q2 | Q2 | 62/158 |
| 2018 | TOXICOLOGY | SCIE | Q1 | Q2 | 16/93 |
| 2017 | IMMUNOLOGY | SCIE | Q2 | Q2 | 71/155 |
| 2017 | TOXICOLOGY | SCIE | Q1 | Q2 | 23/94 |
| 2016 | IMMUNOLOGY | SCIE | Q3 | — | 95/151 |
| 2016 | TOXICOLOGY | SCIE | Q2 | — | 39/92 |
| 2015 | IMMUNOLOGY | SCIE | Q3 | — | 99/151 |
| 2015 | TOXICOLOGY | SCIE | Q2 | — | 43/90 |